Galectin Therapeutics reported $8.3M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Array Technologies Inc ARRY:US 214.49M 46.37M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Galectin Therapeutics GALT:US $ 8.3M 2.24M
Gilead Sciences GILD:US $ 10245M 31M
Idera Pharmaceuticals IDRA:US $ 5.57M 0.46M
Vital Therapies VTL:US $ 10.59M 3.9M
YTE INCY:US $ 742.71M 82.39M